December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tg Therapeutics (NQ: TGTX )

22.60 -1.15 (-4.84%)
Streaming Delayed Price Updated: 11:07 AM EDT, Sep 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Tg Therapeutics

< Previous 1 2 3 4 5 6 7 8 9 Next >
What's Going On With ADMA Biologics Stock Monday?
ADMA Biologics shares are moving higher after it was announced that the company will join the S&P SmallCap 600. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why NASDAQ:TGTX is Poised for High Growth.
Exploring TG THERAPEUTICS INC (NASDAQ:TGTX)'s growth characteristics. 
Via Chartmill
In the world of growth stocks, NASDAQ:TGTX shines as a value proposition.
NASDAQ:TGTX, a growth stock which is not overvalued. 
Via Chartmill
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Decoding TG Therapeutics's Options Activity: What's the Big Picture?
Via Benzinga
Why the growth investor may take a look at NASDAQ:TGTX.
Is TG THERAPEUTICS INC (NASDAQ:TGTX) suited for growth investing? 
Via Chartmill
A Closer Look at TG Therapeutics's Options Market Dynamics
Via Benzinga
NASDAQ:TGTX: a strong growth stock preparing for the next leg up?.
TG THERAPEUTICS INC (NASDAQ:TGTX) qualifies as a high growth stock and is consolidating. 
Via Chartmill
IBD 50 Stock TG Therapeutics Breaks Out Bullishly After 'Solid' Quarter
The company reported a surprise profit in the second quarter, vs. expectations for losses. 
Via Investor's Business Daily
ZIM Integrated Shipping Services Posts Upbeat Earnings, Joins fuboTV, Foghorn Therapeutics And Other Big Stocks Moving Higher On Monday
Via Benzinga
Stock Market Rally Begins After Global Rout; Palantir, Eli Lilly, Fortinet Jump: Weekly Review
After Monday's panicked global sell-off, markets have calmed down. 
Via Investor's Business Daily
NASDAQ:TGTX is showing decent growth, but is still valued reasonably.
NASDAQ:TGTX stands out as a growth opportunity that won't break the bank. 
Via Chartmill
$1000 Invested In TG Therapeutics 5 Years Ago Would Be Worth This Much Today
Via Benzinga
(TGTX) - Analyzing TG Therapeutics's Short Interest
Via Benzinga
Peering Into TG Therapeutics's Recent Short Interest
Via Benzinga
S&P 500 Surges Over 2%; Caterpillar Earnings Beat Estimates
Via Benzinga
Topics Earnings Stocks
Exposures Financial US Equities
Crude Oil Moves Higher; Yum! Brands Posts Upbeat Earnings
Via Benzinga
Exposures Fossil Fuels
TGTX Stock Earnings: TG Therapeutics Beats EPS, Beats Revenue for Q2 2024
TGTX stock results show that TG Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Yum China Posts Upbeat Earnings, Joins Clear Secure, TG Therapeutics, Bioventus And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
(TGTX) - Analyzing TG Therapeutics's Short Interest
Via Benzinga
TG Therapeutics Stock Jumps As Surprise Profit Smashes Views By 157%
The company unexpectedly reported profit in the second quarter, handily beating views for a per-share loss. 
Via Investor's Business Daily
In the world of growth stocks, NASDAQ:TGTX shines as a value proposition.
Looking for growth without the hefty price tag? Consider TG THERAPEUTICS INC (NASDAQ:TGTX). 
Via Chartmill
"Rule Breaker Investing" Market Cap Game Show: Bill Mann vs. Bill Barker
Our first-ever twin bill. 
Via The Motley Fool
Nasdaq 100 Overbought? Here’s What History Says About The Current Rally
Find out the historical patterns traders can look for to anticipate the next move in the Nasdaq 100. 
Via Talk Markets
Why TG Therapeutics Stock Was Rocketing Higher This Week
The company raised guidance for sales of its drug for relapsing multiple sclerosis. 
Via The Motley Fool
Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
TGTX Stock Earnings: TG Therapeutics Misses EPS, Beats Revenue for Q1 2024
TGTX stock results show that TG Therapeutics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
TG Therapeutics stock just rallied 30%: what happened?
TG Therapeutics Inc (NASDAQ: TGTX) is up 30% on Wednesday even though it reported a wider-than-expected per-share loss for its fiscal first quarter. 
Via Talk Markets
Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.